Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Actinium Pharmaceuticals (ATNM)
NYSE MKT:ATNM
Actinium Pharmaceuticals (ATNM) Financial Statements
1,836 Followers
Actinium Pharmaceuticals Financial Overview
| Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | $ 45.00K | $ 45.00K |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -15.64M | $ 11.58M | $ -11.29M | $ -9.80M | $ -7.85M |
| EBITDA | $ -15.43M | $ 11.77M | $ -11.13M | $ -9.58M | $ -7.67M |
| Net Income Common Stockholders | $ -15.18M | $ 12.13M | $ -10.65M | $ -9.47M | $ -7.77M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 91.28M | $ 94.92M | $ 109.31M | $ 111.81M | $ 116.33M |
| Total Assets | $ 99.05M | $ 101.40M | $ 113.59M | $ 116.82M | $ 121.80M |
| Total Debt | $ 9.15M | $ 7.86M | $ 10.63M | $ 2.60M | $ 2.65M |
| Net Debt | $ -82.13M | $ -87.06M | $ -98.68M | $ -109.21M | $ -113.68M |
| Total Liabilities | $ 45.97M | $ 44.82M | $ 47.71M | $ 45.56M | $ 43.62M |
| Stockholders Equity | $ 53.08M | $ 57.21M | $ 66.48M | $ 71.25M | $ 78.18M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -13.69M | $ -15.15M | $ -7.79M | $ -5.79M | $ 27.65M |
| Operating Cash Flow | $ -13.64M | $ -15.08M | $ -7.78M | $ -5.71M | $ 27.92M |
| Investing Cash Flow | $ -47.00K | $ -76.00K | $ -16.00K | $ -73.00K | $ -270.00K |
| Financing Cash Flow | $ 10.05M | $ 770.00K | $ 4.89M | $ 1.57M | $ 16.66M |
Actinium Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.